Singapore markets closed

Lifecore Biomedical, Inc. (LFCR)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
6.39+0.04 (+0.63%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/05/2023
31/05/2022
31/05/2021
31/05/2020
Total revenue
103,269
103,269
111,270
100,874
160,066
Cost of revenue
75,284
75,284
72,204
61,937
120,679
Gross profit
27,985
27,985
39,066
38,937
39,387
Operating expenses
Research development
8,736
8,736
7,839
6,684
7,582
Selling general and administrative
38,969
38,969
34,659
27,721
40,674
Total operating expenses
47,705
47,705
42,498
34,405
48,256
Operating income or loss
-19,720
-19,720
-3,432
4,532
-8,869
Interest expense
17,649
17,649
15,551
8,933
4,646
Total other income/expenses net
-26,627
-26,627
-1,785
-25,434
-17,202
Income before tax
-63,928
-63,928
-20,687
-29,787
-30,645
Income tax expense
308
308
-5,211
-6,350
-8,774
Income from continuing operations
-64,236
-64,236
-15,476
-23,437
-21,871
Net income
-99,563
-99,563
-116,715
-32,294
-38,191
Net income available to common shareholders
-99,563
-99,563
-116,715
-32,294
-38,191
Basic EPS
-3.32
-
-3.97
-1.10
-1.31
Diluted EPS
-3.32
-
-3.97
-1.10
-1.31
Basic average shares
29,958
-
29,466
29,294
29,162
Diluted average shares
29,958
-
29,466
29,294
29,162